Travere Therapeutics, Inc. · NASDAQ:TVTX
Baynes Roy D. sold 32,750 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 14, 2026 · Filed Apr 16, 2026
On Apr 14, 2026, Baynes Roy D. (Director) sold 32,750 Travere Therapeutics, Inc. shares at an average US$41.29 for US$1.35M under a trading plan, leaving 37,500 shares. Filed Apr 16, 2026 (Form 4).
- Sold
- 32,750 shares
- Price
- US$41.29 average (US$41.07 to US$42.12)
- Value
- US$1.35M
- Holding after
- 37,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Common Stock | Option exercise | 8,000 | US$17.94 | 45,500 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 9,000 | US$15.43 | 54,500 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 4,500 | US$18.27 | 59,000 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 4,500 | US$21.38 | 63,500 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 6,750 | US$17.11 | 70,250 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 26,000 | US$41.07 | 44,250 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 6,750 | US$42.12 | 37,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Baynes Roy D.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Baynes Roy D. · Jun 16, 2026
- Form 4 · Baynes Roy D. · May 21, 2026
- Form 4 · Baynes Roy D. · May 6, 2026
- Form 4 · Baynes Roy D. · May 4, 2026
- Form 4 · Baynes Roy D. · Apr 7, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026